136 related articles for article (PubMed ID: 12613005)
1. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.
Kim SJ; Goldstein M; Szabo T; Pierratos A
Am J Kidney Dis; 2003 Mar; 41(3):E12. PubMed ID: 12613005
[TBL] [Abstract][Full Text] [Related]
2. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis.
Van Eps CL; Jeffries JK; Anderson JA; Bergin PT; Johnson DW; Campbell SB; Carpenter SM; Isbel NM; Mudge DW; Hawley CM
Nephrology (Carlton); 2007 Jun; 12(3):224-33. PubMed ID: 17498116
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.
Akasbi N; Houssaini TS; Rabhi S; Lahlou M; Boukhrissa A; Tahiri L; El Maaroufi C; Berrady R; Harzy T; Bono W
J Clin Rheumatol; 2011 Aug; 17(5):272-4. PubMed ID: 21778901
[TBL] [Abstract][Full Text] [Related]
5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis.
Toussaint N; Boddington J; Simmonds R; Waldron C; Somerville C; Agar J
Hemodial Int; 2006 Jul; 10(3):280-6. PubMed ID: 16805890
[TBL] [Abstract][Full Text] [Related]
7. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
Hamada J; Tamai K; Ono W; Saotome K
J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
[TBL] [Abstract][Full Text] [Related]
8. Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report.
Geffriaud C; Allinne E; Page B; Zingraff J; Jucquel JP; Bardin T; Drüeke TB
Clin Nephrol; 1992 Sep; 38(3):158-61. PubMed ID: 1395170
[TBL] [Abstract][Full Text] [Related]
9. Review of dialysate calcium concentration in hemodialysis.
Toussaint N; Cooney P; Kerr PG
Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
[TBL] [Abstract][Full Text] [Related]
10. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis].
Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK
Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679
[TBL] [Abstract][Full Text] [Related]
11. Tumoral calcinosis of the shoulder.
Hung TH; Hung JK; Chang IL; Yu CT; Chen SJ
Int Surg; 2007; 92(5):300-3. PubMed ID: 18399103
[TBL] [Abstract][Full Text] [Related]
12. Sudden onset of parathyroid hormone-independent severe hypercalcemia from reversal of tumoral calcinosis in a dialysis patient.
Kamar FB; Mann B; Kline G
BMC Nephrol; 2016 Sep; 17(1):137. PubMed ID: 27683096
[TBL] [Abstract][Full Text] [Related]
13. Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder.
Maioli ME; Delfino VDA; Guerra ACDZ; Kunii LF; Frange RFN
J Bras Nefrol; 2017; 39(2):217-219. PubMed ID: 29069247
[TBL] [Abstract][Full Text] [Related]
14. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk.
Harris DC; Yuill E; Chesher DW
J Am Soc Nephrol; 1995 Dec; 6(6):1607-12. PubMed ID: 8749687
[TBL] [Abstract][Full Text] [Related]
15. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
16. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
Walsh M; Manns BJ; Klarenbach S; Tonelli M; Hemmelgarn B; Culleton B
Hemodial Int; 2010 Apr; 14(2):174-81. PubMed ID: 20041960
[TBL] [Abstract][Full Text] [Related]
17. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe metastatic calcification in hemodialysis patients.
Yeh SM; Hwang SJ; Chen HC
Hemodial Int; 2009 Apr; 13(2):163-7. PubMed ID: 19432688
[TBL] [Abstract][Full Text] [Related]
19. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
20. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
